Magazine November 30, 2020, Issue

Dan Lipinski and the Decline of Pro-Life Democrats

Representative Dan Lipinski speaks during the March for Life rally in downtown Chicago, January 13, 2019. (Raquel Zaldivar/Chicago Tribune/Tribune News Service via Getty Images)
His House defeat nearly completes his party’s purge of anti-abortion voices

Flossmoor, Ill.

‘I’m from Chicago,” says Con­gressman Dan Lipinski. “When you’re from Chicago, you’re going to be a Democrat.”

And when you’re a Democrat in the House of Representatives, from Chicago or elsewhere, you’re likely to be a few other things, such as a supporter of unions, gun control, and the impeachment of President Trump. This pretty much describes Lipinski’s voting record, too. So far, so predictable.

Another safe bet is that you’re going to favor abortion rights — unless you’re Lipinski, one of America’s last Demo­cratic officeholders who are strongly pro-life. When the House convenes with its new members in 2021, however,

To Read the Full Story

This article appears as “Democrat for Life” in the November 30, 2020, print edition of National Review.

Something to Consider

If you valued reading this article, please consider joining our fight by donating to our Fall Webathon. Your contribution makes it possible for us to continue our mission of speaking truth and defending conservative principles.

If you valued reading this article, please consider joining our fight by donating to our Fall Webathon.


Support Our Mission
John J. Miller, the national correspondent for National Review and host of its Great Books podcast, is the director of the Dow Journalism Program at Hillsdale College. He is the author of A Gift of Freedom: How the John M. Olin Foundation Changed America.

In This Issue


Books, Arts & Manners


The Week

The Week

During the campaign, Democrats used the coronavirus pandemic as a cudgel against Trump and other Republicans.


The Latest

The Wuhan Lab Cover-Up

The Wuhan Lab Cover-Up

It's now certain that the U.S. government misled the public about the kind of research that the U.S. taxpayers were indirectly funding in China.